Results 51 to 60 of about 3,138,639 (136)

Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy

open access: yes, 2021
Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment that uses an antibody-photoabsorber (IRDye700DX) conjugate (APC) that is activated by NIR light irradiation.
Aki Furusawa   +4 more
core   +1 more source

Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy

open access: yes, 2021
Near-infrared photoimmunotherapy (NIR-PIT) employs molecularly targeted antibodies conjugated with a photoabsorbing silicon-phthalocyanine dye derivative which binds to cancer cells.
Ryuhei Okada (7419425)   +27 more
core   +3 more sources

Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts

open access: yesBiomedicines, 2022
Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed and promising therapy that specifically destroys target cells by irradiating antibody-photo-absorber conjugates (APCs) with NIR light.
Hideyuki Furumoto   +5 more
doaj   +1 more source

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin

open access: yesPharmaceutics, 2022
Disialoganglioside (GD2) is a subtype of glycolipids that is highly expressed in tumors of neuroectodermal origins, such as neuroblastoma and osteosarcoma.
Fuyuki F. Inagaki   +8 more
doaj   +1 more source

Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer

open access: yes, 2019
Near-infrared photoimmunotherapy (NIR-PIT) is a new and promising cancer therapy based on a monoclonal antibody conjugated to a photosensitizer which is activated by near-infrared light irradiation, causing cell death.
Takamasa Suzuki   +7 more
core   +1 more source

Evaluation of a Novel Lateral Emitting Laser Fiber for Near-Infrared Photoimmunotherapy. [PDF]

open access: yesCancers (Basel)
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer therapy that uses NIR light and conjugates of a tumor-targeting monoclonal antibody and phthalocyanine dye.
Suzuki M, Kobayashi H, Hanaoka H.
europepmc   +2 more sources

Near-Infrared Photoimmunotherapy for Cancers of the Gastrointestinal Tract

open access: yes, 2020
BACKGROUND: Cancers of the gastrointestinal tract are the common leading cause of cancer-related death in the world. Recent advances in the cancer therapies such as intensive multi-drug chemotherapy and molecular targeted treatment have improved ...
Tadanobu Nagaya   +5 more
core   +1 more source

Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy

open access: yes, 2022
SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a cancer therapy that selectively destroys target cells by first injecting monoclonal antibodies conjugated with a photon absorber (IRDye700DX) into the subject and then activating it at the ...
Furusawa, Aki   +19 more
core   +1 more source

Quickly evolving near‐infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment

open access: yesView, 2022
Among modalities of cancer immunotherapy, near‐infrared photoimmunotherapy (NIR‐PIT) has reached significant preclinical and clinical stages and quickly evolved over the last 5 years.
Hailey Monaco   +3 more
doaj   +1 more source

Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy

open access: yes, 2020
Near-infrared photoimmunotherapy (NIR-PIT) is a highly selective cancer treatment that employs an antibody photoabsorber conjugate (APC) composed of a targeting monoclonal antibody (mAb) conjugated with a photoactivatable phthalocyanine-derivative dye ...
Aki Furusawa   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy